ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,994, issued on Oct. 14, was assigned to BLUEALLELE Corp. (Oakdale, Minn.).
"Methods for targeted insertion of DNA in genes" was invented by Nicholas J. Baltes (Oakdale, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for modifying the coding sequence of endogenous genes using rare-cutting endonucleases and transposases. The methods and compositions described herein can be used to modify the coding sequence of endogenous genes."
The patent was filed on Dec. 1, 2023, under Application No. 18/526,758.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Se...